Functional magnetic resonance imaging in schizophrenia;Imágenes de resonancia magnética funcional en la esquizofrenia

Dialogues in Clinical Neuroscience

Volumn 12, Issue 3, 2010, Pages 333-343

  Gur, Raquel E ^a   Gur, Ruben C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BOLD; Event related; fMRI; Functional connectivity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DYSBINDIN; NEU DIFFERENTIATION FACTOR; OLANZAPINE; RGS4 PROTEIN; RISPERIDONE; NEUROLEPTIC AGENT; OXYGEN;

AFFECTIVE NEUROSIS; AFFECTIVE PSYCHOSIS; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR CHANGE; BLOOD OXYGENATION; COGNITION; COGNITIVE DEFECT; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOMICS; LEARNING DISORDER; NEUROBIOLOGY; NEUROIMAGING; SCHIZOPHRENIA; SOCIAL ASPECT; VISUAL STIMULATION; VULNERABLE POPULATION; BLOOD; BRAIN; DRUG EFFECT; GENETICS; HUMAN; IMAGE PROCESSING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; VASCULARIZATION;

ANTIPSYCHOTIC AGENTS; BRAIN; COGNITION DISORDERS; GENOMICS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; OXYGEN; SCHIZOPHRENIA;

EID: 78049490221     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Meda SA, Stevens MC, Folley BS, Calhoun VD, Pearlson GD. Evidence for anomalous network connectivity during working memory encoding in schizophrenia: an ICA based analysis. PLoS One. 2009;4:e7911.
2. Leitman DI, Wolf DH, Ragland JD, et al. "It's not what you say, but how you say it": a reciprocal temporo-frontal network for affective prosody. Front Hum Neurosci. 2010;4:19-31.
3. Barch DM, Csernansky JG. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction. Am J Psychiatry. 2007;164:1090-1098.
4. Becker TM, Kerns JG, Macdonald AW 3rd, Carter CS. Prefrontal dysfunction in first-degree relatives of schizophrenia patients during a Stroop task. Neuropsychopharmacology. 2008;33:2619-2625.
5. Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophr Bull. 2007;33:921-931.
6. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry. 2009;66:811-822.
7. Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol. 2009;5:249-275.
8. Haenschel C, Bittner R A, Haertling F, et al. Contribution of impaired early-stage visual processing to working memory dysfunction in adolescents with schizophrenia: a study with event-related potentials and functional magnetic resonance imaging. Arch Gen Psychiatry. 2007;64:1229-1240.
9. Tost H, Wolf I, Brassen S, Ruf M, Schmitt A, Braus DF. Visual motion processing dysfunction in schizophrenia: a "bottom up" or "top down" deficit? Neuroimage. 2004;22:374-380.
10. Braus DF, Weber-Fahr W, Tost H, Ruf M, Henn FA. Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2002;59:696-701.
11. Mathalon DH, Whitfield S L, Ford J M. Anatomy of an error: ERP and fMRI. Biol Psychol. 2003;64:119-141.
12. Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry. 2005;62:254-262.
13. Gur R E, Turetsky B I, Loughead J, et al. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. Am J Psychiatry. 2007;164:442-449.
14. Wolf DH, Turetsky BI, Loughead J, et al. Auditory oddball fMRI in schizophrenia: association of negative symptoms with regional hypoactivation to novel distractors. Brain Imaging Behav. 2008;2:132-145.
15. Habel U, Klein M, Shah NJ, et al. Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry. 2004;161:1806-813.
16. Phillips ML, Williams L, Senior C, et al. A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Res. 1999;92:11-31.
17. Gur RE, McGrath C, Chan RM, et al. An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry. 2002;159:1992-1999.
18. Kosaka H, Omori M, Murata T, et al. Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophr Res. 2002;57:87-95.
19. Takahashi H, Koeda M, Oda K, et al. An fMRI study of differential neural response to affective pictures in schizophrenia. Neuroimage. 2004;22:1247-1254.
20. Gur RE, Loughead J, Kohler CG, et al. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Arch Gen Psychiatry. 2007;64:1356-1366.
21. Hunter MD, Ganesan V, Wilkinson ID, Spence SA. Impact of modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry. 2006;163:2184-2186.
22. Wise, RG, Tracey I. The role of fMRI in drug discovery. J Magn Reson Imaging. 2006;23:862-876.
23. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A. 1999; 96:13432-13437.
24. Surguladze SA, Chu EM, Evans A, et al. The effect of long-acting risperidone on working memory in schizophrenia: a functional magnetic resonance imaging study. J Clin Psychopharmacol. 2007;27:560-570.
25. Kumari V, Soni W, Sharma T. Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Schizophr Res. 2002;55:139-146.
26. Callicott J, Egan MF, Mattay V, et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry. 2003;160:709-719.
27. Fusar-Poli P, Perez J, Broome M, et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2007;31:465-484.
28. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98:6917-6922.
29. Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A. 2004;10:12604-12609.
30. Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull. 2003;65:259.
31. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006;7:818-827.